Search
for

    Sort by

    Research 91–120 of 1000+

    1. New Progesterone Esters as 5.ALPHA.-Reductase Inhibitors. Chemical & Pharmaceutical Bulletin · 2001 · 22 citations
    2. Anti-androgenic activities of Ganoderma lucidum Journal of Ethnopharmacology · 2005 · 70 citations
    3. Anti-androgenic activities of the triterpenoids fraction of Ganoderma lucidum Food Chemistry · 2006 · 64 citations
    4. Structure of human type II 5 alpha-reductase gene Endocrinology · 1992 · 76 citations
    5. 11α-Hydroxyprogesterone, a potent 11β-hydroxysteroid dehydrogenase inhibitor, is metabolised by steroid-5α-reductase and cytochrome P450 17α-hydroxylase/17,20-lyase to produce C11α-derivatives of 21-deoxycortisol and 11-hydroxyandrostenedione in vitro The Journal of Steroid Biochemistry and Molecular Biology · 2019 · 7 citations
    6. Mechanisms of testosterone action 2021
    7. The Dutasteride: Miraculous Drug in Alopecia Treatment A Review Zenodo (CERN European Organization for Nuclear Research) · 2023
    8. Current treatment of BPH Biomedicine & pharmacotherapy · 1995 · 11 citations
    9. A Comparison of Varying alpha-Blockers and Other Pharmacotherapy Options for Lower Urinary Tract Symptoms. PubMed · 2005 · 52 citations
    10. Hormonal manipulation of benign prostatic hyperplasia Current opinion in urology · 2012 · 18 citations
    11. Medical Treatment of Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia European urology. Supplement · 2009 · 10 citations
    12. Effect of dose reduction of dutasteride in combination with alpha-blockers in patients with lower urinary tract symptoms/benign prostatic enlargement Urology Annals · 2024 · 2 citations
    13. UTILIZAÇÃO DE FINASTERIDA NO TRATAMENTO DA HIPERPLASIA PROSTÁTICA BENIGNA – RELATO DE CASO Enciclopédia Biosfera · 2023
    14. Effects of Castration on BPH 2016
    15. 5α-Reductase inhibitor therapy: Should physicians be concerned with persistent diminished libido, erectile dysfunction and depression in a subset of patients? Journal of Men's Health · 2010
    16. Associations between semen quality and lower urinary tract symptoms in ageing male Journal of Men's Health · 2010
    17. Lower urinary tract symptoms (LUTS): The role of medications in improvement of quality of life Galenika Medical Journal · 2022
    18. Effects of finasteride in patients with inflammatory chronic pelvic pain syndrome: a double-blind, placebo-controlled, pilot study Urology · 1999 · 65 citations
    19. Macular Abnormalities Associated With 5α-Reductase Inhibitor JAMA Ophthalmology · 2020 · 6 citations
    20. Metformin and malignant neoplasms: a possible mechanism of antitumor action and prospects for use in practice Problemy èndokrinologii · 2022 · 3 citations
    21. Steroid 5α-Reductase Inhibitors Mini-reviews in Medicinal Chemistry · 2003 · 42 citations
    22. 5-Alpha reductase deficiency Current Opinion in Endocrinology, Diabetes and Obesity · 2014 · 38 citations
    23. 12 Treatment of hirsutism with 5α-reductase inhibitors Clinics in endocrinology and metabolism · 1986 · 28 citations
    24. Medikamentöse Therapie des benignen Prostatasyndroms mit α1-Rezeptorblockern Grundlagen und klinische Ergebnisse Der Urologe · 2002 · 22 citations
    25. α-spinasterol from Melandrium firmum attenuates benign prostatic hyperplasia in a rat model Molecular Medicine Reports · 2014 · 15 citations
    26. Impact of Alpha Blockers, 5-alpha Reductase Inhibitors and Combination Therapy on Sexual Function Current Urology Reports · 2014 · 11 citations
    27. Endocrine treatment of benign prostatichypertrophy: Current concepts Urology · 1991 · 11 citations
    28. Chapter 23. Therapeutic Control of Androgen Action Annual Reports in Medicinal Chemistry · 1994 · 7 citations
    29. Most recent findings of curative drugs for lower urinary tract symptoms in clinical practice Nihon Yakuri Gakkai nenkai yoshishu · 2019
    30. Update on medical management of benign prostatic hyperplasia UK vet. Companion animal · 2008